Global T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 96
Inquire Before Buying

Market Analysis and Insights: Global T-Cell Immunotherapy Market

The global T-Cell Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-Cell Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T-Cell Immunotherapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T-Cell Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T-Cell Immunotherapy market.

Global T-Cell Immunotherapy Scope and Market Size

T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- CAR-T

- TCR

- TIL Therapies

Segment by Application

- Stomach Cancer

- Lung Cancer

- Colorectal Cancer

- Esophagus Cancer

- Pancreatic Cancer

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Adaptimmune

- Altor Bioscience Corporation

- Cellectis

- Juno Therapeutics

- Kite Pharma

- Novartis

- Takara Bio

- Unum Therapeutics

Global T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 Market by Application
1.3.1 Global T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophagus Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global T-Cell Immunotherapy Market Perspective (2016-2027)
2.2 T-Cell Immunotherapy Growth Trends by Regions
2.2.1 T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 T-Cell Immunotherapy Industry Dynamic
2.3.1 T-Cell Immunotherapy Market Trends
2.3.2 T-Cell Immunotherapy Market Drivers
2.3.3 T-Cell Immunotherapy Market Challenges
2.3.4 T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Immunotherapy Players by Revenue
3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
3.4 Global T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2020
3.5 T-Cell Immunotherapy Key Players Head office and Area Served
3.6 Key Players T-Cell Immunotherapy Product Solution and Service
3.7 Date of Enter into T-Cell Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 T-Cell Immunotherapy Breakdown Data by Type
4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)
5 T-Cell Immunotherapy Breakdown Data by Application
5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America T-Cell Immunotherapy Market Size (2016-2027)
6.2 North America T-Cell Immunotherapy Market Size by Type
6.2.1 North America T-Cell Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America T-Cell Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America T-Cell Immunotherapy Market Size by Type (2016-2027)
6.3 North America T-Cell Immunotherapy Market Size by Application
6.3.1 North America T-Cell Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America T-Cell Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America T-Cell Immunotherapy Market Size by Application (2016-2027)
6.4 North America T-Cell Immunotherapy Market Size by Country
6.4.1 North America T-Cell Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America T-Cell Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2016-2027)
7.2 Europe T-Cell Immunotherapy Market Size by Type
7.2.1 Europe T-Cell Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe T-Cell Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe T-Cell Immunotherapy Market Size by Type (2016-2027)
7.3 Europe T-Cell Immunotherapy Market Size by Application
7.3.1 Europe T-Cell Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe T-Cell Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe T-Cell Immunotherapy Market Size by Application (2016-2027)
7.4 Europe T-Cell Immunotherapy Market Size by Country
7.4.1 Europe T-Cell Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe T-Cell Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific T-Cell Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type
8.2.1 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific T-Cell Immunotherapy Market Size by Application
8.3.1 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific T-Cell Immunotherapy Market Size by Region
8.4.1 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America T-Cell Immunotherapy Market Size (2016-2027)
9.2 Latin America T-Cell Immunotherapy Market Size by Type
9.2.1 Latin America T-Cell Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America T-Cell Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America T-Cell Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America T-Cell Immunotherapy Market Size by Application
9.3.1 Latin America T-Cell Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America T-Cell Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America T-Cell Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America T-Cell Immunotherapy Market Size by Country
9.4.1 Latin America T-Cell Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America T-Cell Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa T-Cell Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type
10.2.1 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application
10.3.1 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa T-Cell Immunotherapy Market Size by Country
10.4.1 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2016-2021)
11.1.5 Adaptimmune Recent Development
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2016-2021)
11.2.5 Altor Bioscience Corporation Recent Development
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis T-Cell Immunotherapy Introduction
11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2016-2021)
11.3.5 Cellectis Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021)
11.4.5 Juno Therapeutics Recent Development
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2016-2021)
11.5.5 Kite Pharma Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis T-Cell Immunotherapy Introduction
11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Introduction
11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2016-2021)
11.7.5 Takara Bio Recent Development
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021)
11.8.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR
Table 4. Key Players of TIL Therapies
Table 5. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global T-Cell Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global T-Cell Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global T-Cell Immunotherapy Market Share by Regions (2016-2021)
Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global T-Cell Immunotherapy Market Share by Regions (2022-2027)
Table 11. T-Cell Immunotherapy Market Trends
Table 12. T-Cell Immunotherapy Market Drivers
Table 13. T-Cell Immunotherapy Market Challenges
Table 14. T-Cell Immunotherapy Market Restraints
Table 15. Global T-Cell Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global T-Cell Immunotherapy Market Share by Players (2016-2021)
Table 17. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2020)
Table 18. Ranking of Global Top T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Immunotherapy Product Solution and Service
Table 22. Date of Enter into T-Cell Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global T-Cell Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global T-Cell Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Adaptimmune Company Details
Table 63. Adaptimmune Business Overview
Table 64. Adaptimmune T-Cell Immunotherapy Product
Table 65. Adaptimmune Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 66. Adaptimmune Recent Development
Table 67. Altor Bioscience Corporation Company Details
Table 68. Altor Bioscience Corporation Business Overview
Table 69. Altor Bioscience Corporation T-Cell Immunotherapy Product
Table 70. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 71. Altor Bioscience Corporation Recent Development
Table 72. Cellectis Company Details
Table 73. Cellectis Business Overview
Table 74. Cellectis T-Cell Immunotherapy Product
Table 75. Cellectis Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 76. Cellectis Recent Development
Table 77. Juno Therapeutics Company Details
Table 78. Juno Therapeutics Business Overview
Table 79. Juno Therapeutics T-Cell Immunotherapy Product
Table 80. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 81. Juno Therapeutics Recent Development
Table 82. Kite Pharma Company Details
Table 83. Kite Pharma Business Overview
Table 84. Kite Pharma T-Cell Immunotherapy Product
Table 85. Kite Pharma Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 86. Kite Pharma Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis T-Cell Immunotherapy Product
Table 90. Novartis Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Takara Bio Company Details
Table 93. Takara Bio Business Overview
Table 94. Takara Bio T-Cell Immunotherapy Product
Table 95. Takara Bio Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 96. Takara Bio Recent Development
Table 97. Unum Therapeutics Company Details
Table 98. Unum Therapeutics Business Overview
Table 99. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
Table 100. Unum Therapeutics Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. CAR-T Features
Figure 3. TCR Features
Figure 4. TIL Therapies Features
Figure 5. Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2027
Figure 6. Stomach Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Esophagus Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Immunotherapy Report Years Considered
Figure 13. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global T-Cell Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global T-Cell Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 16. Global T-Cell Immunotherapy Market Share by Regions (2022-2027)
Figure 17. Global T-Cell Immunotherapy Market Share by Players in 2020
Figure 18. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2020
Figure 20. Global T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 21. Global T-Cell Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 22. North America T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 24. North America T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 25. North America T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 26. United States T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 30. Europe T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 31. Europe T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 32. Germany T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2016-2027)
Figure 42. China T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 50. Latin America T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 51. Latin America T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 52. Mexico T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa T-Cell Immunotherapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa T-Cell Immunotherapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa T-Cell Immunotherapy Market Share by Country (2016-2027)
Figure 58. Turkey T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 62. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 63. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 64. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 65. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 67. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 68. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • China Non-Hodgkin Lymphoma Therapeutics Market Report & Forecast 2021-2027
    Published: 16-Nov-2021        Price: US 3400 Onwards        Pages: 94
    China Non-Hodgkin Lymphoma Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Non-Hodgkin Lymphoma Therapeutics Market Segment Percentages, By Type, 2020 (%) - Chemotherapy - Targeted Therapy China Non-Hodgkin Lymphoma Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Non-Hodgkin Lymphoma Therapeutics Market Segment Percentages, By Application, 2020 (%) - Clinical Research - Treatment ......
  • China Melanoma Therapeutics Market Report & Forecast 2021-2027
    Published: 15-Nov-2021        Price: US 3400 Onwards        Pages: 93
    China Melanoma Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Melanoma Therapeutics Market Segment Percentages, By Type, 2020 (%) - Chemotherapy - Immunotherapy - Targeted Therapy - Radiation Therapy - Others China Melanoma Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Melanoma Therapeutics Market Segment Percentages, By Application, 2020 (%) - Hospitals - Clinics......
  • China Acute Lymphoblastic Leukemia Therapeutics Market Report & Forecast 2021-2027
    Published: 02-Nov-2021        Price: US 3400 Onwards        Pages: 106
    China Acute Lymphoblastic Leukemia Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Acute Lymphoblastic Leukemia Therapeutics Market Segment Percentages, By Type, 2020 (%) - Chemotherapy - Targeted Therapy - Radiation Therapy - Stem cell Transplantation China Acute Lymphoblastic Leukemia Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Acute Lymphoblastic Leukemia Therapeutics Market Segment......
  • Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021
    Published: 31-Oct-2021        Price: US 2500 Onwards        Pages: 2145
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia - Drugs In Development, 2021, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.Acute lymphocytic leukemia (ALL) is the cancer of the white blood cells due to the production of a large number of immature lymphocytes t......
  • Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
    Published: 31-Oct-2021        Price: US 2500 Onwards        Pages: 1872
    Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia - Drugs In Development, 2021, provides an overview of the Chronic Lymphocytic Leukemia (Oncology) pipeline landscape.Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Sym......
  • Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021
    Published: 31-Oct-2021        Price: US 2000 Onwards        Pages: 815
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia - Drugs In Development, 2021, provides an overview of the Chronic Myelocytic Leukemia (Oncology) pipeline landscape.Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of ......
  • Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021
    Published: 31-Oct-2021        Price: US 2500 Onwards        Pages: 4641
    Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development, 2021, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.Non-Hodgkin lymphoma (also known as non-Hodgkin's lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the body's immune system. S......
  • Chondrosarcoma (Oncology) - Drugs in Development, 2021
    Published: 31-Oct-2021        Price: US 2000 Onwards        Pages: 727
    Chondrosarcoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Drugs In Development, 2021, provides an overview of the Chondrosarcoma (Oncology) pipeline landscape.Chondrosarcoma is a malignant cancer whose tumor cells produce a pure hyaline cartilage that results in abnormal bone and/or cartilage growth. Signs and symptoms include pain in the affected area that may wors......
  • Ewing Sarcoma (Oncology) - Drugs in Development, 2021
    Published: 31-Oct-2021        Price: US 2000 Onwards        Pages: 938
    Ewing Sarcoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma - Drugs In Development, 2021, provides an overview of the Ewing Sarcoma (Oncology) pipeline landscape. Ewing's sarcoma is a primary bone cancer that affects mainly children and adolescents. Ewing's sarcoma can occur any time during childhood and young adulthood, but usually develops during puberty, w......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs